Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1036 of 5804
-
Second chance: new drug tested for stubborn thyroid eye disease
Disease control Recruiting nowThe main objective of this trial is to assess the efficacy of AMG 732 in participants with thyroid eye disease (TED) who are defined as primary nonresponders or relapsed during the safety follow-up in the parent trial (NCT06401044).
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a two-drug combo beat the HTLV-1 virus?
Disease control Recruiting nowThis phase 2b, open-label, randomized controlled trial evaluates the efficacy and safety of dolutegravir (DTG) alone versus dolutegravir combined with tenofovir disoproxil fumarate (TDF) in individuals with HTLV-1 infection and associated clinical manifestations. The primary obje…
Phase: PHASE2 • Sponsor: Carlos Brites • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New at-home device aims to improve bladder control for spinal cord injury patients
Disease control Recruiting nowThe purpose of this study is to determine the safety and efficacy of Injectrode Tibial Nerve Stimulation for bladder function in people with spinal cord injury.
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo trial hopes to tame advanced breast cancer
Disease control Recruiting nowA study to investigate camizestrant in combination with atirmociclib in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer previously treated with a cyclin dependent kinase 4/6 (CDK4/6) inhibitor.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Buddy system: new study tests friend talks to curb Booze-Fueled assaults
Prevention Recruiting nowThis Phase 2 trial will to examine the efficacy of a brief dyad-based motivational interview (PAIRS MI) delivered to friend dyads with an active treatment-as-usual condition, and a 1-year follow-up.
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
Can a common drug protect organs during sepsis?
Disease control ENROLLING_BY_INVITATIONIn this single-center, single-blind, randomized, placebo-controlled pilot trial. The effect of Racecadotril on the improvement of organ function will be investigated in patients with sepsis. Researchers will screen patients admitted to the Department of Critical Care Medicine at …
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a 5-Session therapy help teens with PTSD?
Symptom relief OngoingWritten Exposure Therapy (WET) is a five-session mental health therapy for posttraumatic stress disorder (PTSD). Research shows that it works as well as longer treatments for PTSD among people over 18, even though it requires fewer sessions than other PTSD therapies. However, WET…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Chatbot vs. HPV: 18,000 parents test digital nudge for teen vaccination
Prevention Not yet recruitingThis is an interventional study targeting parents of junior high school girls. The primary objective of the study is to evaluate the effectiveness of a vaccine chatbot in improving HPV vaccination rates among parents' junior high school girls. The secondary objectives are to eval…
Phase: NA • Sponsor: Xiamen University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
New shot could ease IBS-D symptoms in major trial
Symptom relief Recruiting nowThe purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Diarrhea (IBS-D). The study drug will be administered subcutaneously (SC) (under the skin…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New hope for kids with rare nerve disease: satralizumab trial begins
Disease control Recruiting nowThis study will primarily evaluate the pharmacokinetics of satralizumab in pediatric patients aged 2-11 years with anti-aquaporin-4 (AQP4) antibody seropositive neuromyelitis optica spectrum disorder (NMOSD). Efficacy, safety, tolerability, and pharmacodynamics will be evaluated …
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New antibody drug aims to ease lung blood pressure
Disease control Recruiting nowThis study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The s…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Cancer drug adagrasib offers continued hope in rollover trial
Disease control Recruiting nowThis is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung canc…
Phase: PHASE2 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Ear zaps may soothe painful side effect of breast cancer drugs
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether transcutaneous auricular vagus nerve stimulation, also called taVNS, can help relieve aromatase inhibitor-related joint and muscle pain in adult women with hormone receptor-positive breast cancer. The main questions this study …
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
Disease control Recruiting nowThis Phase 3, randomized, double-blind, active-controlled study evaluates the efficacy and safety of obicetrapib (OBI) compared to bempedoic acid (BPA) in participants with dyslipidemia at high or very high cardiovascular risk. Participants must have elevated low density lipoprot…
Phase: PHASE3 • Sponsor: A. Menarini International Licensing S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Breast cancer trial lets early response guide treatment switch
Disease control Recruiting nowThis prospective, response-adapted phase II study evaluates the efficacy and safety of neoadjuvant culmerciclib in combination with aromatase inhibitors in patients with highly proliferative ER-positive/HER2-negative breast cancer. All patients initially receive induction treatme…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Taurine: a simple supplement to fight radiation mouth sores?
Symptom relief Not yet recruitingThis clinical trial aims to understand whether taurine can prevent and reduce severe radiation-induced oral mucositis in patients with nasopharyngeal carcinoma undergoing radiotherapy.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New brain zapping technique shows promise for Parkinson's movement
Symptom relief Recruiting nowThis study aimed to observe the clinical efficacy and safety of single-target transcranial temporal stimulation (tTIS) intervention in Parkinson's disease (PD) patients and explore the neurophysiological mechanism of TIS intervention. The study was designed as a three-arm (A: GPi…
Phase: NA • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Diabetes drug could fight rare brain cancer in kids
Disease control Recruiting nowThis is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma.
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Firefighters' diet study aims to cut cancer risk with station-based nutrition program
Prevention Recruiting nowFirefighters may be at increased risk of poor dietary habits due to nature of shift work, extended duty periods, and reliance on food available within fire station environments. Irregular working patterns and limited access to healthy food options during shifts can contribute to …
Phase: NA • Sponsor: Avon Fire and Rescue Service • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
New digital toolkit aims to transform care for millions with multiple chronic diseases
Disease control Not yet recruitingMultiple Long-Term Conditions (MLTC), defined as the coexistence of two or more chronic conditions, is increasingly prevalent in India. Despite this, the healthcare system remains largely focused on single-disease management, underscoring the urgent need for integrated, patient-c…
Phase: NA • Sponsor: Centre for Chronic Disease Control, India • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC